000 01488 a2200397 4500
005 20250513085720.0
264 0 _c19960501
008 199605s 0 0 eng d
022 _a0344-5704
024 7 _a10.1007/s002800050402
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aEdelman, M J
245 0 0 _aPromising new agents in the treatment of non-small cell lung cancer.
_h[electronic resource]
260 _bCancer chemotherapy and pharmacology
_c1996
300 _a385-93 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAminopterin
_xanalogs & derivatives
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aAntineoplastic Agents, Phytogenic
_xtherapeutic use
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aCamptothecin
_xanalogs & derivatives
650 0 4 _aCarcinoma, Non-Small-Cell Lung
_xdrug therapy
650 0 4 _aClinical Trials as Topic
650 0 4 _aDeoxycytidine
_xanalogs & derivatives
650 0 4 _aDocetaxel
650 0 4 _aHumans
650 0 4 _aLung Neoplasms
_xdrug therapy
650 0 4 _aPaclitaxel
_xanalogs & derivatives
650 0 4 _aTaxoids
650 0 4 _aVinblastine
_xanalogs & derivatives
650 0 4 _aVinorelbine
650 0 4 _aGemcitabine
700 1 _aGandara, D R
773 0 _tCancer chemotherapy and pharmacology
_gvol. 37
_gno. 5
_gp. 385-93
856 4 0 _uhttps://doi.org/10.1007/s002800050402
_zAvailable from publisher's website
999 _c8598908
_d8598908